ABEONA THERAPEUTICS INC. 8-K

What Happened

• Abeona Therapeutics, Inc. filed a Current Report on Form 8-K dated June 10, 2026, disclosing a Regulation FD disclosure (Item 7.01).
• The company furnished an updated investor presentation (Exhibit 99.1) that it expects to use, in whole or in part, in presentations to investors, analysts and others. The filing also includes the cover page interactive data file (Exhibit 104).

Key Details

• Filing date: June 10, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Exhibit 99.1: "Abeona Therapeutics Inc. Presentation," dated June 10, 2026 (Investor Presentation).
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) is included.

Why It Matters

• The updated investor presentation is the primary disclosure in this filing; investors should review Exhibit 99.1 for any refreshed corporate information, strategic updates, program or pipeline highlights, or investor guidance the company chooses to disclose.
• Because this was furnished under Regulation FD, the company is broadly disseminating information it intends to use in outreach to the market. This 8-K does not report earnings, executive changes, or other financial statements.